MEDP

MEDP

USD

Medpace Holdings Inc. Common Stock

$594.530+8.583 (1.465%)

即時價格

Healthcare
Diagnostics & Research
美國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$585.947

最高

$599.990

最低

$580.451

交易量

0.05M

公司基本面

市值

16.7B

行業

Diagnostics & Research

國家

United States

交易統計

平均交易量

0.34M

交易所

NMS

貨幣

USD

52週範圍

最低 $250.05當前 $594.530最高 $625

相關新聞

Reuters

Indian pharmacy retailer MedPlus profit jumps with store opening push

Medplus Health Services , one of India's top retail pharmacy chains, reported a 43.3% rise in second-quarter profit on Friday, driven by higher sales from new store openings and steady demand for its private label products.

查看更多
Indian pharmacy retailer MedPlus profit jumps with store opening push
Analyst Upgrades

TD Cowen Maintains Sell on Medpace Hldgs, Raises Price Target to $462

TD Cowen analyst Charles Rhyee maintains Medpace Hldgs with a Sell and raises the price target from $356 to $462.

查看更多
TD Cowen Maintains Sell on Medpace Hldgs, Raises Price Target to $462
Analyst Upgrades

Barclays Maintains Underweight on Medpace Hldgs, Raises Price Target to $485

Barclays analyst Luke Sergott maintains Medpace Hldgs with a Underweight and raises the price target from $425 to $485.

查看更多
Barclays Maintains Underweight on Medpace Hldgs, Raises Price Target to $485
Analyst Upgrades

Mizuho Maintains Outperform on Medpace Hldgs, Raises Price Target to $655

Mizuho analyst Ann Hynes maintains Medpace Hldgs with a Outperform and raises the price target from $575 to $655.

查看更多
Mizuho Maintains Outperform on Medpace Hldgs, Raises Price Target to $655
Analyst Upgrades

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins

Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 guidance.

查看更多
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins
BusinessWire

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Revenue of $659.9 million in the third quarter of 2025 increased 23.7% from revenue of $533.3 million for the comparable prior-year period, representing a backlog conversion rate of 23.0%. Net new business awards